Premarket Mover: Emergent Biosolutions Inc (EBS) Up 1.27%

Emergent Biosolutions Inc (EBS) is up Wednesday morning, with the stock climbing 1.27% in pre-market trading to 2.39. EBS's short-term technical score of 9 indicates that the stock has traded less bullishly over the last month than 91% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 122 out of 146 industries, EBS ranks higher than 15% of stocks. Emergent Biosolutions Inc has fallen 21.07% over the past month, closing at $2.99 on October 11. During this period of time, the stock fell as low as $1.96 and as high as $3.24. EBS has an average analyst recommendation of Sell. The company has an average price target of $13.50.

EBS has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on EBS!

See Full EBS Report

Emergent Biosolutions Inc has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 93 by this metric, EBS ranks better than 93% of stocks.

Important Dates for Investors in EBS:

-Emergent Biosolutions Inc is set to release earnings on 2024-01-31. Over the last 12 months, the company has reported EPS of $-12.09. -We do not have a set dividend date for Emergent Biosolutions Inc at this time. Click Here To Get The Full Report on Emergent Biosolutions Inc (EBS)